Christopher W. Cain
Insider
First SEC filing: June 11, 2026 · Latest: June 11, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2026 | VRDN | A | 32,341 | · | · | 32,341 Indirect | · | Acquired | (price as of 2026-10-02) |
| June 9, 2026 | COGT | A | 17,901 | · | · | 17,901 Direct | · | Acquired | (price as of 2026-10-02) |
| June 9, 2026 | JBIO | A | 34,843 | · | · | 34,843 Direct | · | Acquired | (price as of 2026-10-02) |
| March 23, 2026 | DMRA | A | 37,313 | · | · | 37,313 Direct | · | Acquired | (price as of 2026-10-02) |
| July 1, 2025 | VRDN | A | 21,000 | · | · | 21,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| June 4, 2025 | COGT | A | 44,700 | · | · | 44,700 Direct | · | Acquired | (price as of 2026-10-02) |
| April 29, 2025 | JBIO | A | 23,017 | · | · | 23,017 Direct | · | Acquired | (price as of 2026-10-02) |
| March 10, 2025 | VRDN | A | 42,000 | · | · | 42,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| June 5, 2024 | COGT | A | 44,700 | · | · | 44,700 Direct | · | Acquired | (price as of 2026-10-02) |
| June 7, 2023 | COGT | A | 36,700 | · | · | 36,700 Direct | · | Acquired | (price as of 2026-10-02) |
| June 7, 2022 | COGT | A | 30,700 | · | · | 30,700 Direct | · | Acquired | (price as of 2026-10-02) |
| March 11, 2021 | COGT | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 27, 2020 | COGT | A | 28,661 | · | · | 28,661 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2026 | VRDN | Stock Option (Right to Buy) | Common Stock | $18.48 | July 1, 2036 | 32,341 | Acquired |
| June 9, 2026 | COGT | Stock Option (Right to Buy) | Common Stock | $31.98 | June 9, 2036 | 17,901 | Acquired |
| June 9, 2026 | JBIO | Stock Option (Right to Buy) | Common Stock | $15.22 | June 8, 2036 | 34,843 | Acquired |
| March 23, 2026 | DMRA | Stock Option (right to buy) | Common Stock | $23.05 | March 23, 2036 | 37,313 | Acquired |
| July 1, 2025 | VRDN | Stock Option (Right to Buy) | Common Stock | $14.47 | July 1, 2035 | 21,000 | Acquired |
| June 4, 2025 | COGT | Stock Option (Right to Buy) | Common Stock | $5.64 | June 4, 2035 | 44,700 | Acquired |
| April 29, 2025 | JBIO | Stock Option (Right to Buy) | Common Stock | $10.14 | April 29, 2035 | 23,017 | Acquired |
| March 10, 2025 | VRDN | Stock Option (Right to Buy) | Common Stock | $15.58 | March 10, 2035 | 42,000 | Acquired |
| June 5, 2024 | COGT | Stock Option (Right to Buy) | Common Stock | $8.92 | June 5, 2034 | 44,700 | Acquired |
| June 7, 2023 | COGT | Stock Option (Right to Buy) | Common Stock | $11.70 | June 7, 2033 | 36,700 | Acquired |
| June 7, 2022 | COGT | Stock Option (Right to Buy) | Common Stock | $4.59 | June 7, 2032 | 30,700 | Acquired |
| March 11, 2021 | COGT | Stock Option (Right to Buy) | Common Stock | $8.45 | March 11, 2031 | 60,000 | Acquired |
| Aug. 27, 2020 | COGT | Director Stock Option (Right to Buy) | Common Stock | $2.77 | Aug. 27, 2030 | 28,661 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).